Neurologic Disorders
VIDEO: ANA president discusses ‘fantastic sessions’ from annual meeting
In this video, M. Elizabeth Ross, MD, PhD, FANA, president of the American Neurological Association, spoke with Healio about some of the most memorable sessions from the ANA Annual Meeting and looks ahead to next year’s meeting.
BLOG: Optometry’s expanding role in medical care
I recently read an interesting article that came in on my Healio news feed, which featured research by Wendy Harrison, OD, PhD, and colleagues on corneal hysteresis as a biomarker for prediabetes.
Top in endocrinology: Compounded semaglutide dosing errors; type 1 diabetes immunotherapy
The FDA has received reports of adverse events, including gastrointestinal events, fainting, headache, migraine, dehydration, acute pancreatitis and gallstones, that may be tied to overdosing with compounded semaglutide.
Semaglutide does not raise risk for neurologic disorders for adults with type 2 diabetes
Semaglutide was not associated with increased risks for adverse neurologic or psychological disorders at 1 year compared with other diabetes drugs, according to data published in eClinicalMedicine.
Neuro care for those with limited language proficiency requires multimodal approach
PHILADELPHIA — Language training, communication among patients, caregivers and clinicians, and limited treatment wait times are needed for those with limited language proficiency to receive required neurological care, according to a poster.
Cognivue reports nearly 40% participation rate from marginalized groups in FOCUS study
The national Further the Objective and Clinical Understanding of Cognivue Study drew a 37% research participation rate from individuals in underserved and underrepresented populations, the neuroscience company reported in a press release.
Hunting for Better Outcomes: Management Options for Huntington’s Disease
This activity is supported by an educational grant from Sage Therapeutics.
Blinkcns, Zucker Institute partner on blink reflex technology for neurological disorders
Blinkcns Inc. and the Zucker Institute for Innovation Commercialization at the Medical University of South Carolina have announced a licensing agreement to advance blink reflex technology and software EyeStat.
VeriSIM Life, Total Brain to develop drugs for broad range of neurological disorders
VeriSIM Life announced it will partner with neuroscience firm Total Brain to develop new drugs for the treatment of a wide range of neurological disorders, the company announced through a press release.
Pose estimation provides quick, accurate motion tracking for neuro patients
Pose estimation may be a quick, accurate alternative for measuring full-body movements during neurological examinations, according to a pilot study published in PLOS One.